Page last updated: 2024-08-17

quinoxalines and Atrial Fibrillation

quinoxalines has been researched along with Atrial Fibrillation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, SA; Chen, YC; Chen, YJ; Cheng, CC; Higa, S; Hu, YF	1

Other Studies

1 other study(ies) available for quinoxalines and Atrial Fibrillation

Article	Year
Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway. Journal of cardiovascular electrophysiology, 2009, Volume: 20, Issue:2 Topics: Action Potentials; Androstadienes; Animals; Atrial Fibrillation; Blotting, Western; Electrophysiology; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Heart Atria; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Indoles; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oncogene Protein v-akt; Oxadiazoles; Phosphatidylinositol 3-Kinases; Pulmonary Veins; Quinoxalines; Rabbits; Signal Transduction; Wortmannin	2009

Article

Year

Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway.

Journal of cardiovascular electrophysiology, 2009, Volume: 20, Issue:2

Topics: Action Potentials; Androstadienes; Animals; Atrial Fibrillation; Blotting, Western; Electrophysiology; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Heart Atria; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Indoles; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oncogene Protein v-akt; Oxadiazoles; Phosphatidylinositol 3-Kinases; Pulmonary Veins; Quinoxalines; Rabbits; Signal Transduction; Wortmannin

2009